Omega 3, Atrial Fibrillation, and Cardiovascular Outcomes
J Am Coll Cardiol
.
2023 Nov 21;82(21):e201-e202.
doi: 10.1016/j.jacc.2023.08.059.
Authors
Evan L O'Keefe
1
,
Carl J Lavie
2
,
Andrew Elagizi
3
,
Richard V Milani
3
,
Jari A Laukkanen
4
Affiliations
1
University of Missouri-Kansas City, Kansas City, Missouri, USA.
2
Ochsner Clinical School-The UQ School of Medicine, New Orleans, Louisiana, USA. Electronic address: clavie@ochsner.org.
3
Ochsner Clinical School-The UQ School of Medicine, New Orleans, Louisiana, USA.
4
University of Eastern Finland, Kupio, Finland.
PMID:
37968024
PMCID:
PMC10829855
DOI:
10.1016/j.jacc.2023.08.059
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Comment
MeSH terms
Atrial Fibrillation* / epidemiology
Cardiovascular System*
Fatty Acids, Omega-3* / therapeutic use
Heart
Humans
Substances
Fatty Acids, Omega-3
Grants and funding
T32 HL110837/HL/NHLBI NIH HHS/United States